Mechanisms of solute release from porous hydrophilic polymers RW Korsmeyer, R Gurny, E Doelker, P Buri, NA Peppas International journal of pharmaceutics 15 (1), 25-35, 1983 | 6412 | 1983 |
Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs RW Korsmeyer, NA Peppas Journal of membrane Science 9 (3), 211-227, 1981 | 595 | 1981 |
Application of compressed carbon dioxide in the incorporation of additives into polymers AR Berens, GS Huvard, RW Korsmeyer, FW Kunig Journal of Applied Polymer Science 46 (2), 231-242, 1992 | 397 | 1992 |
Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling RW Korsmeyer, SR Lustig, NA Peppas Journal of Polymer Science Part B: Polymer Physics 24 (2), 395-408, 1986 | 361 | 1986 |
Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air RW Korsmeyer, R Gurny, E Doelker, P Buri, NA Peppas Journal of pharmaceutical sciences 72 (10), 1189-1191, 1983 | 336 | 1983 |
Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models RW Korsmeyer, E Von Meerwall, NA Peppas Journal of Polymer Science Part B: Polymer Physics 24 (2), 409-434, 1986 | 331 | 1986 |
Macromolecular and modeling aspects of swelling-controlled systems RW Korsmeyer, NA Peppas Controlled release delivery systems 1983 (77-90), 83, 1983 | 329 | 1983 |
Dynamically swelling hydrogels in controlled release applications NA Peppas, RW Korsmeyer Hydrogels in medicine and pharmacy 3, 109-136, 1987 | 312 | 1987 |
Solute and penetrant diffusion in swellable polymers. III. Drug release from glassy poly (HEMA-co-NVP) copolymers RW Korsmeyer, NA Peppas Journal of Controlled Release 1 (2), 89-98, 1984 | 275 | 1984 |
An EP2 receptor-selective prostaglandin E2 agonist induces bone healing VM Paralkar, F Borovecki, HZ Ke, KO Cameron, B Lefker, WA Grasser, ... Proceedings of the National Academy of Sciences 100 (11), 6736-6740, 2003 | 244 | 2003 |
Asymmetric-membrane tablet coatings for osmotic drug delivery SM Herbig, JR Cardinal, RW Korsmeyer, KL Smith Journal of Controlled Release 35 (2-3), 127-136, 1995 | 238 | 1995 |
Use of asymmetric membranes in delivery devices JR Cardinal, SM Herbig, RW Korsmeyer, J Lo, KL Smith, AG Thombre US Patent 5,612,059, 1997 | 170 | 1997 |
Asymmetric membranes in delivery devices JR Cardinal, SM Herbig, RW Korsmeyer, J Lo, KL Smith, AG Thombre US Patent 5,698,220, 1997 | 162 | 1997 |
Controlled-release dosage forms of azithromycin WJ Curatolo, HL Friedman, RW Korsmeyer, SR LeMott US Patent 6,068,859, 2000 | 143 | 2000 |
Controlled release delivery systems RW Korsmeyer, NA Peppas TJ Roseman and SZ Mansdorf, M. Dekker, New York, 77-90, 1983 | 84 | 1983 |
Process for incorporating an additive into a polymer and product produced thereby AR Berens, GS Huvard, RW Korsmeyer US Patent 4,820,752, 1989 | 71 | 1989 |
Macromolecular network structure and its effects on drug and protein diffusion CT Reinhart, RW Korsmeyer, NA Peppas Int. J. Pharm. Tech 2 (9), 1981 | 58 | 1981 |
Preparation of cyclohexanones and cyclopentanones of high optical purity DF Taber, SA Saleh, RW Korsmeyer The Journal of Organic Chemistry 45 (23), 4699-4702, 1980 | 58 | 1980 |
Critical questions in development of targeted nanoparticle therapeutics R Korsmeyer Regenerative Biomaterials 3 (2), 143-147, 2016 | 38 | 2016 |
Combination dosage form comprising cetirizine and pseudoephedrine BA Johnson, RW Korsmeyer, CA Oksanen US Patent 6,171,618, 2001 | 35 | 2001 |